PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Phenotype | C0011849|diabetes mellitus |
| Sentences | 44 |
| PubMedID- 24843443 | Furthermore, anemia is accompanied by cardiovascular events9–12, mortality13 and mortality after acute myocardial infarction16 in patients with diabetes mellitus. |
| PubMedID- 21576196 | An increased incidence of myocardial infarction with rosiglitazone in patients with type 2 diabetes mellitus (t2dm) has been reported. |
| PubMedID- 23459575 | Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus. |
| PubMedID- 20843380 | We therefore set out to investigate the association between individual oral glucose-lowering drugs and cardiovascular outcomes following myocardial infarction in patients with diabetes mellitus not treated with emergent percutaneous coronary intervention. |
| PubMedID- 23226370 | Although clinical outcomes of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus (t2dm) is well established to be worse than non-diabetic patients [1], [2], the reasons for this remain unclear. |
| PubMedID- 26379783 | The exclusion criteria were: type 2 diabetes mellitus, history of myocardial infarction, clinically significant valvular heart disease, chronic kidney disease, chronic liver disease, chronic obstructive pulmonary disease, smoking (>20 cigarettes/day), polytherapy, obstructive sleep apnea. |
| PubMedID- 21318153 | The uk prospective diabetes study 34 revealed that the risk of diabetes-related death and the incidence of myocardial infarction associated with diabetes mellitus could be decreased with metformin therapy [24]. |
| PubMedID- 24254885 | However, they do not constitute sufficient evidence to indicate the routine use of chelation therapy for all post-myocardial infarction patients with diabetes mellitus. |
| PubMedID- 20965878 | diabetes mellitus in patients with myocardial infarction complicated by heart failure: a 'low ejection fraction' equivalent. |
| PubMedID- 22783203 | In these analyses, we regarded the following data as covariates for multivariate analysis: age category (70–74, 75–79, 80–84 years); sex; bmi (continuous variable); hypertension, hypercholesterolemia, diabetes mellitus, history of stroke, myocardial infarction, or angina pectoris, liver diseases, renal diseases (presence or absence); cognitive function (mini-mental state examination score of <24 or ≥24); depressive symptoms (geriatric depression scale scores of <11 or ≥11); smoking (never, former, and current smoker); use of alcohol (never, former, and currently drinking); use of tranquilizer (yes or no); physical functioning status (mos scores [continuous variables]); leisure-time physical activity (level 1: no sports, no brisk walking, no walking; level 2: no sports, no brisk walking; low amount of walking; level 3: no sports, no brisk walking, high amount of walking; level 4: no sports, low amount of brisk walking, any amount of walking; level 5: no sports, high amount of brisk walking, any amount of walking; level 6: any amount of sports, any amounts of brisk walking, any amount of walking). |
| PubMedID- 23403268 | In multivariate cox analyses adjusting for age, sex, race, diabetes mellitus, history of heart failure, myocardial infarction, ischemic heart disease, stroke, smoking, serum high-density lipoprotein cholesterol, creatinine, glucose, and urine albumin/creatinine ratio as standard risk factors, and for incident myocardial infarction, in-treatment use of digoxin, systolic and diastolic pressure, heart rate, qrs duration, cornell voltage-duration product, and sokolow-lyon voltage left ventricular hypertrophy treated as time-varying covariates, new-onset af remained associated with a >3-fold increased risk of scd (hazard ratio, 3.13; 95% confidence interval, 1.87-5.24; p<0.001). |
| PubMedID- 22498999 | Cardiac remodeling and heart failure after a first anterior myocardial infarction in patients with diabetes mellitus. |
| PubMedID- 26410961 | Hyperleptinemia and its relationship with myocardial necrosis markers (creatine phosphokinase, creatine phosphokinase-mb, troponin) give reason to suggest the important role of leptin in the development of inflammatory process associated with myocardial infarction in patients with and without diabetes mellitus. |
| PubMedID- 20211319 | In conclusion, an eesbpr was associated with improved survival and a lower rate of death or myocardial infarction in patients with diabetes mellitus and known or suspected cad. |
| PubMedID- 19759031 | We compared lipids, lipid peroxidation product malondialdehyde (mda), the acute phase reactant high-sensitivity c-reactive protein (hscrp), interleukin 1beta (il-1beta), and platelet selectin (p-selectin) between healthy controls, type 2 diabetes mellitus (dm) participants without myocardial infarction (mi), as well as type 2 dm participants with mi. |
| PubMedID- 23108517 | Baseline characteristics, such as age, gender, diabetes mellitus, history of previous myocardial infarction, killip class on admission and ecg pattern (including information regarding any bundle branch blocks – old, new or of unknown origin) were analysed. |
| PubMedID- 25193670 | Effects of baseline coronary occlusion and diabetes mellitus in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. |
| PubMedID- 26279482 | Aims: to assess the risk of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus treated with long-acting insulin analogues in comparison with other basal insulin therapy. |
| PubMedID- 24386093 | Independent determinants of cardiovascular events (myocardial infarction, stroke, death) in patients with pad and diabetes mellitus. |
| PubMedID- 22436146 | Importantly, the study population only included persons at risk for myocardial infarction (persons with hypertension, diabetes mellitus and/or dyslipidemia) and "healthy user" bias possibly occurred in selecting controls [19,20]. |
| PubMedID- 26445676 | In addition, patients who survive aki have worse long-term outcomes than patients with diabetes mellitus and survivors of an st-elevation myocardial infarction [4, 5]. |
| PubMedID- 26341185 | Comparison of changes in global longitudinal peak systolic strain after st-segment elevation myocardial infarction in patients with versus without diabetes mellitus. |
| PubMedID- 25411597 | These results might be clinically meaningful if the levels could be maintained long term, as it has been reported that a reduction of hba1c by 1% has been associated with a 21% reduction in the relative risk of death, 37% reduction in risk of microvascular complications and 14% reduction in risk of myocardial infarction15 in patients with type 2 diabetes mellitus. |
| PubMedID- 26209521 | Low concentrations of serum testosterone predict acute myocardial infarction in men with type 2 diabetes mellitus. |
| PubMedID- 21539643 | Heart rate turbulence can predict cardiac mortality following myocardial infarction in patients with diabetes mellitus. |
| PubMedID- 24773097 | Incremental costs associated with myocardial infarction and stroke in patients with type 2 diabetes mellitus: an overview for economic modeling. |
| PubMedID- 21907990 | We investigated whether snp rs4788102, which captures the entire sh2b1 variability, is associated with coronary artery disease (cad) and/or myocardial infarction (mi) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 23933608 | Age, killip class, diabetes mellitus, history of stroke and myocardial infarction were independent predictors of death. |
| PubMedID- 24399329 | Risk of ischemic stroke after an acute myocardial infarction in patients with diabetes mellitus. |
| PubMedID- PMC3952941 | Exclusion criteria were clinical coronary artery disease, chronic renal disease, diabetes mellitus, hypertension, history of myocardial infarction, angina pectoris or cerebrovascular disease, dyslipidemia, metabolic syndrome or active infection. |
| PubMedID- 21393298 | Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure. |
| PubMedID- 20431807 | Materials and methods: 30 type 2 diabetes mellitus cases with myocardial infarction and equal members of type 2 diabetics without complications are enrolled. |
| PubMedID- 22679279 | Relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism, angiographically defined coronary artery disease and myocardial infarction in patients with type 2 diabetes mellitus. |
| PubMedID- 24229770 | Although pioglitazone significantly prevented the progression of coronary atherosclerosis and reduced the recurrence of myocardial infarction in patients with type 2 diabetes mellitus (dm), it remains unclear whether pioglitazone could attenuate coronary artery inflammation. |
| PubMedID- 19395095 | Aims: the presence of diabetes mellitus (dm) in patients with myocardial infarction (mi) increases mortality, due in part to the presence of known cardiovascular risk factors. |
| PubMedID- 23960432 | We are intrigued this study conducted as a student project for 3 months, with strict criteria excluding patients with systolic blood pressure >170 mmhg and <100 mmhg, diabetes mellitus, past history of myocardial infarction, renal impairment, hepatic impairment, cerebrovascular event, moderate to severe heart failure, bradycardia, second to third degree heart block, arrhythmias, history of drug intake namely diltiazem, verapamil, beta blockers, simvastatin, digoxin, amiodarone, phenytoin etc., could still manage to recruit a sizeable number of patients for such a short period. |
| PubMedID- 24529823 | Glycemic variability predicts cardiovascular complications in acute myocardial infarction patients with type 2 diabetes mellitus. |
| PubMedID- 20640879 | In men, serum cholesterol level and high-density lipoprotein level, diabetes mellitus and history of myocardial infarction were key risk factors for chd. |
| PubMedID- 22858312 | Association of manganese superoxide dismutase and glutathione s-transferases genotypes with myocardial infarction in patients with type 2 diabetes mellitus. |
| PubMedID- 23286208 | Furthermore, short- and long-term survival following a myocardial infarction is lower in patients with type 2 diabetes mellitus compared to those without[4-8]. |
| PubMedID- 20484611 | Recent meta-analyses suggest an increased risk of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus (t2dm) treated with rosiglitazone. |
| PubMedID- 21444887 | Background: in the bypass angioplasty revascularization investigation 2 diabetes (bari 2d) trial, an initial strategy of coronary revascularization and optimal medical treatment (rev) compared with an initial optimal medical treatment with the option of subsequent revascularization (med) did not reduce all-cause mortality or the composite of cardiovascular death, myocardial infarction, and stroke in patients with type 2 diabetes mellitus and stable ischemic heart disease. |
| PubMedID- 20478050 | More data are required not only for efficacy, but also to address the long-term safety of rosiglitazone in these patients, particularly in light of the recent report that rosiglitazone is associated with a significant increase in the risk of myocardial infarction in patients with type 2 diabetes mellitus [55]. |
| PubMedID- 25356815 | Exclusion criteria were age less than 35 years, type 1 diabetes mellitus, ecg evidence of q-wave myocardial infarction, ischemic st-segment or t-wave changes, or complete left-bundle branch block, a clinical history of cv disease, cerebrovascular disease, or malignancy, and an estimated modification of diet in renal disease gfr less than 60 ml/min/1.73 m2. |
Page: 1